tirzepatide 2023788-19-2 china factory high purity 99.8% loss wight

Email: sales2@qschem-pharma.com Whatsapp/Telegarm/Signal: +8619521323435 Tirzepatide is a once-weekly dual agonist of glucose-dependent insulinotropic peptide (GIP, also known as: gastric inhibitory peptide) receptor and glucagon-like peptide-1 (GLP-1) receptor, developed by Eli Lilly . ChemicalbookGIP and GLP-1 are both hormones secreted by the intestine and can promote insulin secretion. Tirzepatide combines two insulinotropic effects into a single molecule and represents a new class of drugs for the treatment of type 2 diabetes.

Dec 26, 2023 - 02:30
0 24
tirzepatide 2023788-19-2 china factory high purity 99.8% loss wight
tirzepatide 2023788-19-2 china factory high purity 99.8% loss wight Email: sales2@qschem-pharma.com
Whatsapp/Telegarm/Signal: +8619521323435


Tirzepatide is a once-weekly dual agonist of glucose-dependent insulinotropic peptide (GIP, also known as: gastric inhibitory peptide) receptor and glucagon-like peptide-1 (GLP-1) receptor, developed by Eli Lilly . ChemicalbookGIP and GLP-1 are both hormones secreted by the intestine and can promote insulin secretion. Tirzepatide combines two insulinotropic effects into a single molecule and represents a new class of drugs for the treatment of type 2 diabetes.
Click here for details